Pet IV fluid supplies market seen reaching $1.72 billion by 2030

The Business Research Company projects steady growth in the pet intravenous fluid supplies market, with the segment rising from $1.16 billion in 2025 to $1.72 billion by 2030. The forecast points to pet ownership gains, expanding veterinary services and broader use of advanced infusion systems as the main growth drivers.

Why it matters: - Rising pet ownership and more advanced veterinary care are increasing demand for sterile IV fluids, electrolytes, nutrients and drug delivery supplies used in animal treatment. - The market’s growth signals more spending on emergency, specialty and routine veterinary care, especially for dehydration, kidney disease and critical-care cases.

What happened: - The Business Research Company released a 2026 report on the global pet intravenous (IV) fluid supplies market. - The market is projected to grow from $1.16 billion in 2025 to $1.25 billion in 2026. - The report forecasts the market will reach $1.72 billion by 2030. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the report. - View the full report.

The details: - The market’s recent growth was tied to limited availability of sterile veterinary IV consumables, reliance on basic fluid therapy, low adoption of advanced critical-care infrastructure, modest pet healthcare spending in emerging regions and low awareness of intensive care options for animals. - The forecast growth is linked to wider use of sophisticated veterinary infusion systems, more investment in veterinary healthcare infrastructure, greater penetration of pet insurance, more specialty and emergency veterinary hospitals, and a stronger focus on precision dosing and monitoring. - Pet intravenous fluid supplies are sterile medical products used to deliver fluids, electrolytes, nutrients and drugs directly into an animal’s bloodstream. - These supplies support hydration, stabilize physiological functions and help with treatments that require controlled fluid administration. - The products are manufactured under strict safety and quality controls to ensure sterility, compatibility and dependable performance in veterinary settings. - Increasing pet ownership is a major driver of demand. - Urbanization is pushing more city residents to seek pets for companionship and emotional support in smaller living spaces. - Shelter Animals Count reported 4,192,443 dog and cat adoptions in the US in 2024, including 2 million dogs and 2 million cats, up 0.4% from the prior year. - Expansion of veterinary services is also lifting demand as more clinics add critical care and routine IV therapy. - The American Veterinary Medical Association reported US veterinary practices saw revenue rise about 2.5% in 2025. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

Between the lines: - The forecast suggests pet care is shifting from basic treatment toward more intensive, hospital-style medicine. - Growth in insurance coverage and specialty hospitals could make IV therapy more routine across a wider range of clinics. - The regional split points to a mature North American market and faster expansion opportunity in Asia-Pacific.

What's next: - Veterinary providers are likely to keep expanding infusion capabilities and critical-care offerings as pet spending rises. - Market growth will likely depend on how quickly clinics in emerging regions adopt advanced equipment and higher-acuity care models. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.